These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19186350)

  • 1. Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
    Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):369-76. PubMed ID: 19186350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.
    Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
    AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.
    Brown TT; Li X; Cole SR; Kingsley LA; Palella FJ; Riddler SA; Chmiel JS; Visscher BR; Margolick JB; Dobs AS
    AIDS; 2005 Sep; 19(13):1375-83. PubMed ID: 16103768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women.
    Frasco MA; Karim R; Van Den Berg D; Watanabe RM; Anastos K; Cohen M; Gange SJ; Gustafson DR; Liu C; Tien PC; Mack WJ; Pearce CL
    AIDS; 2014 Jul; 28(12):1815-23. PubMed ID: 24932614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens.
    Gianotti N; Muccini C; Galli L; Poli A; Spagnuolo V; Andolina A; Galizzi N; Ripa M; Messina E; Piatti PM; Lazzarin A; Castagna A
    J Med Virol; 2019 Nov; 91(11):1937-1943. PubMed ID: 31286527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: a longitudinal analysis.
    Mutimura E; Hoover DR; Shi Q; Dusingize JC; Sinayobye JD; Cohen M; Anastos K
    PLoS One; 2015; 10(4):e0123936. PubMed ID: 25880634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.
    Lo JC; Kazemi MR; Hsue PY; Martin JN; Deeks SG; Schambelan M; Mulligan K
    Clin Infect Dis; 2005 Nov; 41(9):1335-40. PubMed ID: 16206112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients.
    Loko MA; Bani-Sadr F; Winnock M; Lacombe K; Carrieri P; Neau D; Morlat P; Serfaty L; Dabis F; Salmon D;
    J Viral Hepat; 2011 Jul; 18(7):e307-14. PubMed ID: 21692942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
    Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
    HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.
    Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA
    Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy.
    Palacios R; Merchante N; Macias J; González M; Castillo J; Ruiz J; Márquez M; Gómez-Mateos J; Pineda JA; Santos J
    Antivir Ther; 2006; 11(4):529-35. PubMed ID: 16856627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between diet and physical activity on insulin resistance in the Women's Interagency HIV Study.
    Hessol NA; Ameli N; Cohen MH; Urwin S; Weber KM; Tien PC
    J Acquir Immune Defic Syndr; 2013 Jan; 62(1):74-80. PubMed ID: 23075914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
    Mallal SA; John M; Moore CB; James IR; McKinnon EJ
    AIDS; 2000 Jul; 14(10):1309-16. PubMed ID: 10930144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants.
    Adeyemi OM; Livak B; Orsi J; Glesby MJ; Villacres MC; Weber KM; Sharma A; Golub E; Young M; Cohen M; Tien PC
    AIDS Patient Care STDS; 2013 Jun; 27(6):320-5. PubMed ID: 23675750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women's Interagency HIV Study (WIHS).
    Valcour V; Rubin LH; Tien P; Anastos K; Young M; Mack W; Cohen M; Golub ET; Crystal H; Maki PM
    J Neurovirol; 2015 Aug; 21(4):415-21. PubMed ID: 25740539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
    Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
    AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
    Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
    Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
    AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.